פריוויג'ן

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

IMMUNOGLOBULINS, NORMAL HUMAN

から入手可能:

CSL BEHRING LTD., ISRAEL

ATCコード:

J06BA02

医薬品形態:

תמיסה לאינפוזיה

構図:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

投与経路:

תוך-ורידי

処方タイプ:

מרשם נדרש

製:

CSL BEHRING AG, SWITZERLAND

治療群:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

治療領域:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

適応症:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

承認日:

2016-06-30